GlassScriptPhysician profile
Eva Jayne Clark
NPI 1669096269
$1,261.35
in general payments reported to CMS, 2019-2025
19 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $330 · 2024: $315 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.88 |
| Education | $119.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $356.46 | 2022-2024 | |
| Janssen Biotech, INC. | $171.35 | 2024-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $119.80 | 2024-2025 | |
| Pfizer INC. | $92.16 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $83.67 | 2024-2025 | Dupixent |
| Evofem Biosciences, INC. | $62.74 | 2022 | |
| Sun Pharmaceutical Industries INC. | $51.84 | 2025 | |
| Exeltis, USA INC. | $39.90 | 2023-2024 | Slynd |
| Exact Sciences Corporation | $39.16 | 2023-2024 | Cologuard Collection Kit |
| Galderma Laboratories, L.P. | $36.32 | 2025 | Nemluvio |
| Genzyme Corporation | $34.87 | 2025 | |
| Shield Therapeutics INC | $34.29 | 2023-2024 | Accrufer |
| Mycovia Pharmaceuticals, INC. | $30.80 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $22.52 | 2023 | Gardasil 9 |
| Amgen INC. | $22.04 | 2023 | Evenity, Prolia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $20.56 | 2025 | Bf-Rhodoled |
| Organon LLC | $15.77 | 2022 | |
| Myriad Women'S Health, INC. | $14.36 | 2023 | Myrisk |
| Avion Pharmaceuticals | $12.74 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.